Safeguard Scientifics reports Q2 net income of $0.5M; Moxe dilution gain; exploring strategic alternatives

SAFEGUARD SCIENTIFICS INC

2022-Q2 EPS reported -$0.38

Net income of $0.5M ($0.03/diluted EPS) vs net loss of $0.3M ($0.02 loss/share) in Q2 2021.
Moxe raised $30M equity, diluting Safeguard's ownership to 19.4%, generating a $5.3M non-cash dilution gain.
Repurchased 221,479 shares in Q2 at avg $4.27, totaling $0.9M; remaining authorization $1.1M.
Continues working with Houlihan Lokey to explore strategic alternatives to maximize shareholder value.
Expects 2022 corporate expenses at low-end or below $3.5-4.0M; deployments may hit upper half of $5-9M range.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.